Doç. Dr. ZEYNEP ULUTAŞ

Yayın Ağı

Makaleler 11

1. Three- and Nine-Month Follow-Up of Patients with COVID-19: Clinical, Functional, and Radiological Outcomes

Değer M., Kılıç T., Ulutaş Z., Tan M. S., Ödümlü H., Atila A., et al.

Journal of Clinical Medicine , cilt.15, sa.13, 2026 (SCI-Expanded, Scopus)

2. Electro-Mechanical Cardiac Remodeling in Metabolic Syndrome: Association Between Frontal QRS-T Angle and Subclinical Left Ventricular Dysfunction Assessed by Four-Dimensional Echocardiography

ULUTAŞ Z., Yigit Y., Karaagac M., CANSEL M.

Journal of Clinical Medicine , cilt.15, sa.13, 2026 (SCI-Expanded, Scopus)

3. Rationale and Design of the Türkiye Heart Failure (TURK-HF) Registry

Kocabas U., MURAT S., Kıvrak T., Murat B., Altın C., Yıldız C., et al.

Clinical Cardiology , cilt.49, sa.5, 2026 (SCI-Expanded, Scopus)

4. ChatGPT response consistency to the 2025 ESC/EACTS guidelines for the management of valvular heart disease: A test–retest study using binary and multiple-choice questions

Mirzaoğlu Ç., ULUTAŞ Z., Karaca Y.

Digital Health , cilt.12, 2026 (SCI-Expanded, SSCI, Scopus)

5. Comparison of cilomilast, tadalafil, and both drug combinations in the treatment of monocrotaline-induced pulmonary arterial hypertension in rats

ERMİŞ N., ÖZHAN O., YILDIZ A., ULUTAŞ Z., PARLAKPINAR H., ULU A., et al.

BMC Cardiovascular Disorders , cilt.25, sa.1, 2025 (SCI-Expanded, Scopus)

6. Effects of CAPE on biochemical, histopathological and cardiac parameters in doxorubicin induced cardiotoxicity

DİŞLİ O. M., AKÇA B., ERDİL N., ÖZHAN O., DURHAN M., YILDIZ A., et al.

NORTHERN CLINICS OF ISTANBUL = ISTANBUL KUZEY KLINIKLERI , cilt.12, sa.5, ss.587-596, 2025 (ESCI, Scopus, TRDizin)

7. The protective and therapeutic effects of agmatine on isoproterenol-induced myocardial injury in rats

Ulutaş Z., Tapsız S., Özhan O., Sarıhan M. E., Yıldız A., Durhan M., et al.

Medicine Science , cilt.12, 2023 (TRDizin)

8. The protective effects of glycyrrhizin on doxorubicin-induced cardiotoxicity in rats

Ulutaş Z., Alıcı M., Ozhan O., Colak M. C., Yıldız A., Arslan A. K., et al.

Annals of Medical Research , cilt.30, sa.10, ss.1276-1282, 2023 (TRDizin)

9. The protective effect of naringenin on ciprofloxacin-induced cardiovascular toxicity in rats

Ulutaş Z., Kurutkan S., Özhan O., Yıldız A., Ulu A., Şahin Büyükkorkmaz L., et al.

ScopeMed , cilt.4, 2023 (Hakemli Dergi)

10. Effects of mirtazapine on cisplatin cardiotoxicity in rats

ÖZHAN O., ULUTAŞ Z., Serduman S., ŞAHİN BÜYÜKKORKMAZ L., YILDIZ A., ULU A., et al.

Medicine Science , cilt.12, sa.2, ss.579-586, 2023 (TRDizin)

11. Successful Bronchial Artery Embolization after Stabilization with Nitric Oxide for the Treatment of Haemoptysis in a Patient with Eisenmenger Syndrome

ULUTAŞ Z., KULOĞLU H. E., KUTLU R., ERMİŞ N.

TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY , cilt.50, sa.6, ss.459-462, 2022 (ESCI, Scopus, TRDizin)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 5

1. Protective Effects of Sulfasalazine in a Doxorubicin-Induced Myocarditis Model in Rats

Kaya E., Taşolar M. H., Balkar M. E., Özhan O., Yıldız A., Doğru F., et al.

3rd INTERNATIONAL AND 28th NATIONAL PHARMACOLOGY CONGRESS, Antalya, Türkiye, 20 - 23 Kasım 2025, (Özet Bildiri)

2. Protective Effects of Molsidomine in Rats with Sepsis Induced by Cecal Ligation and Puncture Method

Köse A., Balkar M. E., Özhan O., Doğru F., Keser Z. B., Ulutaş Z., et al.

3rd INTERNATIONAL AND 28th NATIONAL PHARMACOLOGY CONGRESS, Antalya, Türkiye, 20 - 23 Kasım 2025, (Özet Bildiri)

3. Modifiye kardiyotorasik indeksin kardiyak fonksiyonlarla ilişkisinin derin öğrenme yöntemleri ile değerlendirilmesi

TAŞOLAR M. H., GÜRAL Y., DEMİRÖZ TAŞOLAR S., GÜNEN M. A., ULUTAŞ Z., BAYRAMOĞLU A., et al.

1. Endokrin Kardiyovasküler Renal Hastalıklar ve Aciller Kongresi, Girne, Kıbrıs (Kktc), 2 - 05 Haziran 2022, (Özet Bildiri)

4. The effect of angiotensin II type 2 receptor agonist treatment on doxorubicin induced heart failure

ERMİŞ N., ÖZHAN O., ULUTAŞ KURNAZ Z., VARDI N., ÇOLAK C., PARLAKPINAR H.

ESC Congress 2016, Roma, İtalya, 28 - 31 Ağustos 2016, ss.1, (Tam Metin Bildiri)

5. The effect of angiotensin II type 2 receptor agonist treatment on doxorubicin induced heart failure